{"nct_id":"NCT06239480","title":"SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2024-07-31","start_date_type":"ACTUAL","primary_completion_date":"2026-01","primary_completion_date_type":"ESTIMATED","completion_date":"2026-07","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["PVLA"]}